Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 300
Filter
Add more filters

Complementary Medicines
Publication year range
2.
Biol Pharm Bull ; 44(8): 1037-1043, 2021.
Article in English | MEDLINE | ID: mdl-34334489

ABSTRACT

Dry skin is a common symptom of various conditions, and elderly individuals commonly exhibit this physiological symptom. Dry skin develops owing to sebum deficiency; however, the use of moisturizers can typically overcome this issue, particularly in patients in whom there are no other skin problems. If dry skin is left untreated, itching and eczema can occur, resulting in skin damage. Additionally, hemodialysis patients exhibit reduced barrier function and can experience pain associated with repeated needle insertion; the repeated use of lidocaine tape to manage the pain can cause further skin damage. To reduce the occurrence of dry skin, the skin is hydrated using moisturizers. Dry skin is also prominent in patients with varicose veins in the lower extremities, and many biochemical studies have shown that skin immunity is altered in patients with dry skin. Moreover, the incidences of dry skin and pruritus differ in male and female patients. Furthermore, in elderly patients, zinc deficiency is likely to cause dry skin, and zinc supplementation may maintain skin hydration. To date, few reports have described dry skin from a clinical point of view. In this review, research on dry skin is presented, and the findings of basic research studies are integrated.


Subject(s)
Deficiency Diseases/drug therapy , Dermatologic Agents/therapeutic use , Skin Diseases/drug therapy , Skin/pathology , Varicose Veins , Zinc/therapeutic use , Age Factors , Animals , Deficiency Diseases/complications , Deficiency Diseases/pathology , Dietary Supplements , Eczema/etiology , Eczema/prevention & control , Female , Humans , Lidocaine , Male , Needles , Pain/etiology , Pruritus/etiology , Pruritus/prevention & control , Renal Dialysis , Sex Factors , Skin Diseases/etiology , Skin Diseases/pathology , Zinc/deficiency
3.
Nutrients ; 13(7)2021 Jun 22.
Article in English | MEDLINE | ID: mdl-34206577

ABSTRACT

BACKGROUND: In recent years, trace elements (TEs) have gained considerable attention in the course of treatment and diagnosis of ischemic stroke. The purpose of the conducted research was to determine the trace mineral status (Se, Cu, Zn, Cu/Zn ratio, and Cu/Se ratio) in patients with acute ischemic stroke compared to the population of healthy people in the northeastern region of Poland. MATERIALS AND METHODS: 141 patients with acute ischemic stroke (AIS) and 69 healthy control subjects were examined. The serum concentrations of mineral components were assessed by the atomic absorption spectrometry method. Clinical parameters were updated based on medical records. RESULTS: The serum Se and Zn concentrations were significantly decreased (p < 0.0001; p < 0.0001) in patients with AIS compared with healthy control subjects. However, no significant differences were revealed in terms of the serum Cu concentration (p = 0.283). As expected, we found that the serum Cu/Zn and Cu/Se molar ratios were significantly higher (p = 0.001; p < 0.0001) in patients with AIS compared with healthy control subjects. CONCLUSIONS: Disturbed metal homeostasis is a significant contributor to AIS pathogenesis. Furthermore, marked disruption of the serum Cu/Zn and Cu/Se molar ratios could serve as a valuable indicator of AIS patients' nutritional status and oxidative stress levels.


Subject(s)
Copper/blood , Ischemic Stroke/blood , Selenium/blood , Trace Elements/blood , Zinc/blood , Acute Disease , Adult , Aged , Case-Control Studies , Deficiency Diseases/complications , Deficiency Diseases/epidemiology , Deficiency Diseases/physiopathology , Female , Humans , Ischemic Stroke/etiology , Male , Middle Aged , Nutritional Status , Oxidative Stress , Poland/epidemiology , Spectrophotometry, Atomic
4.
Nutrients ; 13(6)2021 Jun 20.
Article in English | MEDLINE | ID: mdl-34203015

ABSTRACT

The interplay between inflammation and oxidative stress is a vicious circle, potentially resulting in organ damage. Essential micronutrients such as selenium (Se) and zinc (Zn) support anti-oxidative defense systems and are commonly depleted in severe disease. This single-center retrospective study investigated micronutrient levels under Se and Zn supplementation in critically ill patients with COVID-19 induced acute respiratory distress syndrome (ARDS) and explored potential relationships with immunological and clinical parameters. According to intensive care unit (ICU) standard operating procedures, patients received 1.0 mg of intravenous Se daily on top of artificial nutrition, which contained various amounts of Se and Zn. Micronutrients, inflammatory cytokines, lymphocyte subsets and clinical data were extracted from the patient data management system on admission and after 10 to 14 days of treatment. Forty-six patients were screened for eligibility and 22 patients were included in the study. Twenty-one patients (95%) suffered from severe ARDS and 14 patients (64%) survived to ICU discharge. On admission, the majority of patients had low Se status biomarkers and Zn levels, along with elevated inflammatory parameters. Se supplementation significantly elevated Se (p = 0.027) and selenoprotein P levels (SELENOP; p = 0.016) to normal range. Accordingly, glutathione peroxidase 3 (GPx3) activity increased over time (p = 0.021). Se biomarkers, most notably SELENOP, were inversely correlated with CRP (rs = -0.495), PCT (rs = -0.413), IL-6 (rs = -0.429), IL-1ß (rs = -0.440) and IL-10 (rs = -0.461). Positive associations were found for CD8+ T cells (rs = 0.636), NK cells (rs = 0.772), total IgG (rs = 0.493) and PaO2/FiO2 ratios (rs = 0.504). In addition, survivors tended to have higher Se levels after 10 to 14 days compared to non-survivors (p = 0.075). Sufficient Se and Zn levels may potentially be of clinical significance for an adequate immune response in critically ill patients with severe COVID-19 ARDS.


Subject(s)
COVID-19 Drug Treatment , Critical Illness/therapy , Deficiency Diseases/drug therapy , Dietary Supplements , Micronutrients/therapeutic use , Selenium/therapeutic use , Zinc/therapeutic use , Aged , C-Reactive Protein/metabolism , COVID-19/blood , COVID-19/immunology , Deficiency Diseases/complications , Humans , Immune System/drug effects , Inflammation/blood , Inflammation/drug therapy , Intensive Care Units , Interleukins/blood , Male , Micronutrients/blood , Micronutrients/deficiency , Middle Aged , Oxygen/metabolism , Respiratory Distress Syndrome/drug therapy , Retrospective Studies , SARS-CoV-2 , Selenium/blood , Selenium/deficiency , Selenoprotein P/blood , Severity of Illness Index , Zinc/blood , Zinc/deficiency
5.
Clin Nutr ESPEN ; 43: 276-282, 2021 06.
Article in English | MEDLINE | ID: mdl-34024527

ABSTRACT

BACKGROUND AND AIM: COVID-19 is a global public health concern. As no standard treatment has been found for it yet, several minerals and vitamins with antioxidants, immunomodulators, and antimicrobials roles can be sufficient for the immune response against the disease. The present study evaluates the serum vitamin D, calcium, and Zinc levels in patients with COVID-19. MATERIALS & METHODS: This research is a case-control study performed in May 2020 on 93 patients with COVID-19 hospitalized in a Shoushtar city hospital and on 186 healthy subjects with no symptoms of COVID-19. The serum vitamin D, calcium, and zinc levels were collected and analyzed using correlation coefficient and independent t-test via SPSS 18. RESULTS: Vitamin D levels had a significant difference between the case and control groups (p = 0.008). Serum calcium and serum zinc levels also had statistically significant differences between the two groups (p < 0.001). CONCLUSION: The research results showed that serum zinc, calcium, and vitamin D levels in COVID-19 patients are lower than in the control group. The supplementation with such nutrients is a safe and low-cost measure that can help cope with the increased demand for these nutrients in risk of acquiring the COVID-19 virus.


Subject(s)
COVID-19/blood , Calcium/blood , Deficiency Diseases/blood , Nutritional Status , Vitamin D/blood , Zinc/blood , Adult , Anti-Infective Agents/blood , Antioxidants/metabolism , COVID-19/complications , COVID-19/prevention & control , Calcium/deficiency , Case-Control Studies , Cities , Deficiency Diseases/complications , Deficiency Diseases/prevention & control , Dietary Supplements , Female , Hospitalization , Hospitals , Humans , Immunologic Factors/blood , Iran , Male , Micronutrients/blood , Middle Aged , Pandemics , SARS-CoV-2 , Urban Population
6.
Nutrients ; 13(4)2021 Apr 02.
Article in English | MEDLINE | ID: mdl-33918317

ABSTRACT

Diet and nutrition are fundamental in maintaining the general health of populations, including women's health. Health status can be affected by nutrient deficiency and vice versa. Gene-nutrient interactions are important contributors to health management and disease prevention. Nutrition can alter gene expression, as well as the susceptibility to diseases, including cancer, through several mechanisms. Gynecological diseases in general are diseases involving the female reproductive system and include benign and malignant tumors, infections, and endocrine diseases. Benign diseases such as uterine fibroids and endometriosis are common, with a negative impact on women's quality of life, while malignant tumors are among the most common cause of death in the recent years. In this comprehensive review article, a bibliographic search was performed for retrieving information about nutrients and how their deficiencies can be associated with gynecological diseases, namely polycystic ovary syndrome, infertility, uterine fibroids, endometriosis, dysmenorrhea, and infections, as well as cervical, endometrial, and ovarian cancers. Moreover, we discussed the potential beneficial impact of promising natural compounds and dietary supplements on alleviating these significant diseases.


Subject(s)
Deficiency Diseases/therapy , Genital Diseases, Female/therapy , Nutrition Therapy/trends , Deficiency Diseases/complications , Deficiency Diseases/physiopathology , Female , Genital Diseases, Female/etiology , Genital Diseases, Female/physiopathology , Humans , Nutritional Status
7.
Pediatr Res ; 89(7): 1627-1640, 2021 05.
Article in English | MEDLINE | ID: mdl-33010794

ABSTRACT

This manuscript includes (1) a narrative review of Zinc as an essential nutrient for fetal and neonatal growth and brain growth and development and (2) a scoping review of studies assessing the effects of Zinc supplementation on survival, growth, brain growth, and neurodevelopment in neonates. Very preterm infants and small for gestational age infants are at risk for Zinc deficiency. Zinc deficiency can cause several complications including periorificial lesions, delayed wound healing, hair loss, diarrhea, immune deficiency, growth failure with stunting, and brain atrophy and dysfunction. Zinc is considered essential for oligodendrogenesis, neurogenesis, neuronal differentiation, white matter growth, and multiple biological and physiological roles in neurobiology. Data support the possibility that the critical period of Zinc delivery for brain growth in the mouse starts at 18 days of a 20-21-day pregnancy and extends during lactation and in human may start at 26 weeks of gestation and extend until at least 44 weeks of postmenstrual age. Studies are needed to better elucidate Zinc requirement in extremely low gestational age neonates to minimize morbidity, optimize growth, and brain growth, prevent periventricular leukomalacia and optimize neurodevelopment. IMPACT: Zinc is essential for growth and brain growth and development. In the USA, very preterm small for gestational age infants are at risk for Zinc deficiency. Data support the possibility that the critical period of Zinc delivery for brain growth in the mouse starts at 18 days of a 20-21-day pregnancy and extends during lactation and in human may start at 26 weeks' gestation and extend until at least 44 weeks of postmenstrual age. Several randomized trials of Zinc supplementation in neonates have shown improvement in growth when using high enough dose, for long duration in patients likely to or proven to have a Zinc deficiency. Studies are needed to better elucidate Zinc requirement in extremely low gestational age neonates to minimize morbidity, optimize growth and brain growth, prevent periventricular leukomalacia and optimize neurodevelopment.


Subject(s)
Brain/growth & development , Growth , Zinc/physiology , Deficiency Diseases/complications , Female , Fetal Blood/metabolism , Fetus/metabolism , Humans , Infant, Newborn , Infant, Premature , Maternal-Fetal Exchange , Pregnancy , Pregnancy Complications , Zinc/deficiency , Zinc/metabolism
8.
Nutrients ; 12(8)2020 Aug 07.
Article in English | MEDLINE | ID: mdl-32784601

ABSTRACT

OBJECTIVES: The novel coronavirus infection (COVID-19) conveys a serious threat globally to health and economy because of a lack of vaccines and specific treatments. A common factor for conditions that predispose for serious progress is a low-grade inflammation, e.g., as seen in metabolic syndrome, diabetes, and heart failure, to which micronutrient deficiencies may contribute. The aim of the present article was to explore the usefulness of early micronutrient intervention, with focus on zinc, selenium, and vitamin D, to relieve escalation of COVID-19. METHODS: We conducted an online search for articles published in the period 2010-2020 on zinc, selenium, and vitamin D, and corona and related virus infections. RESULTS: There were a few studies providing direct evidence on associations between zinc, selenium, and vitamin D, and COVID-19. Adequate supply of zinc, selenium, and vitamin D is essential for resistance to other viral infections, immune function, and reduced inflammation. Hence, it is suggested that nutrition intervention securing an adequate status might protect against the novel coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome - coronavirus-2) and mitigate the course of COVID-19. CONCLUSION: We recommended initiation of adequate supplementation in high-risk areas and/or soon after the time of suspected infection with SARS-CoV-2. Subjects in high-risk groups should have high priority as regards this nutritive adjuvant therapy, which should be started prior to administration of specific and supportive medical measures.


Subject(s)
Betacoronavirus , Coronavirus Infections/drug therapy , Micronutrients/therapeutic use , Nutritional Status , Pneumonia, Viral/drug therapy , Selenium/therapeutic use , Vitamin D/therapeutic use , Zinc/therapeutic use , COVID-19 , Coronavirus Infections/immunology , Coronavirus Infections/virology , Deficiency Diseases/complications , Disease Progression , Female , Humans , Inflammation/prevention & control , Male , Pandemics , Pneumonia, Viral/immunology , Pneumonia, Viral/virology , SARS-CoV-2
9.
Int J Mol Sci ; 20(22)2019 Nov 14.
Article in English | MEDLINE | ID: mdl-31739389

ABSTRACT

Deficiencies in methyl donors, folate, and vitamin B12 are known to lead to brain function defects. Fetal development is the most studied but data are also available for such an impact in elderly rats. To compare the functional consequences of nutritional deficiency in young versus adult rats, we monitored behavioral outcomes of cerebellum and hippocampus circuits in the offspring of deficient mother rats and in adult rats fed a deficient diet from 2 to 8 months-of-age. We present data showing that the main deleterious consequences are found in young ages compared to adult ones, in terms of movement coordination and learning abilities. Moreover, we obtained sex and age differences in the deleterious effects on these functions and on neuronal layer integrity in growing young rats, while deficient adults presented only slight functional alterations without tissue damage. Actually, the cerebellum and the hippocampus develop and maturate according to different time lap windows and we demonstrate that a switch to a normal diet can only rescue circuits that present a long permissive window of time, such as the cerebellum, whereas the hippocampus does not. Thus, we argue, as others have, for supplements or fortifications given over a longer time than the developmental period.


Subject(s)
Brain/metabolism , Brain/physiopathology , Deficiency Diseases/complications , Deficiency Diseases/metabolism , Fetal Development , Neurodevelopmental Disorders/etiology , Neurodevelopmental Disorders/metabolism , Animals , Cognition , Deficiency Diseases/etiology , Diet , Disease Models, Animal , Female , Folic Acid Deficiency/complications , Folic Acid Deficiency/metabolism , Hippocampus/metabolism , Hippocampus/physiopathology , Male , Maze Learning , Rats
10.
Food Chem Toxicol ; 134: 110813, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31505237

ABSTRACT

Zinc is required for fetal development and is involved in key processes associated with breast carcinogenesis. We evaluated whether maternal zinc deficiency or supplementation during gestation influences female offspring susceptibility to breast cancer in adulthood. C57BL/6 mice consumed during gestation control (30 p.p.m. zinc), zinc-deficient (8 p.p.m) or zinc-supplemented (45 p.p.m.) diets. Maternal zinc supplementation increased in female mice offspring the incidence of chemically-induced mammary adenocarcinomas that were heavier, compared to control group. This was accompanied by a decreased number of terminal end buds, increased cell proliferation and apoptosis, and increased tumor suppressors p21, p53 and Rassf1, Zfp382 and Stat3 expression in mammary glands, as well as increased zinc status. Although maternal zinc deficiency did not alter the incidence of these lesions, it also induced heavier mammary adenocarcinomas, compared to control group. These effects were accompanied by a decreased number of terminal end buds, increased proto-oncogenes c-Myc and Lmo4 expression and H3K9Me3 and H4K20Me3 epigenetic marks in mammary glands of offspring, and decreased zinc status and increased levels of oxidative marker malondialdehyde. The data suggest that both maternal zinc deficiency and supplementation during gestation programmed increased breast cancer susceptibility in adult mice offspring following a J-shaped pattern through distinct mechanisms.


Subject(s)
Deficiency Diseases/complications , Dietary Supplements , Mammary Neoplasms, Experimental/etiology , Zinc/administration & dosage , Zinc/deficiency , Animals , Apoptosis , Cell Proliferation , Female , Gene Expression Profiling , Male , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred C57BL , Pregnancy , Proto-Oncogene Proteins p21(ras)/metabolism , Proto-Oncogenes , Tumor Suppressor Protein p53/metabolism
11.
Korean J Intern Med ; 34(3): 459-469, 2019 May.
Article in English | MEDLINE | ID: mdl-31048656

ABSTRACT

Vascular calcification (VC) and malnutrition associated with cardiovascular disease are common in patients with chronic kidney disease (CKD) treated with dialysis. VC, which reflects vascular aging, and malnutrition are also encountered in the non-CKD elderly population. This similarity of clinical findings suggests that the progression of CKD is related to aging and the existence of a causal relationship between VC and malnutrition. To retard renal progression, a low- or very-low-protein diet is usually recommended for CKD patients. Dietary education may induce malnutrition and deficiency of important nutrients, such as vitamins K and D. Menaquinone-7, a type of vitamin K2, is under investigation for inhibiting VC in elderly patients without CKD, as well as for prevention of VC in patients with CKD. Nutritional vitamin D, such as cholecalciferol, may be considered to decrease the required dose of active vitamin D, which increases the risk of VC due to increased calcium and phosphate loads. Omega-3 fatty acids are important nutrients and their ability to inhibit VC needs to be evaluated in clinical trials. This review focuses on the ability of supplementary nutrients to prevent VC in patients with CKD, in whom dietary restriction is essential.


Subject(s)
Deficiency Diseases/complications , Dietary Supplements , Renal Insufficiency, Chronic/complications , Vascular Calcification/prevention & control , Humans , Risk Factors , Vascular Calcification/etiology
12.
J Pak Med Assoc ; 69(5): 722-724, 2019 May.
Article in English | MEDLINE | ID: mdl-31105296

ABSTRACT

A 12-year-old boy who underwent gastric wedge resection was transferred to our hospital because of vomiting, growth failure, and weight loss in January, 2016. We tried to restore his general condition by maintaining additional nutritional supply through peripheral parenteral nutrition (PN). However, continuous vomiting, weight loss, and superior mesenteric artery syndrome persisted because of low treatment compliance. The findings of hyponatraemia and bicytopenia did not improve. Bone marrow biopsy was performed, and it revealed copper deficiency. PN with additional micronutrient agents, including copper, were administered. In particular, invasive diagnosis and treatment, and adequate education improved the treatment compliance of the child. His copper deficiency and bicytopenia improved, and his weight and dietary intake also increased. We confirmed that treatment compliance is important in paediatric patients with malnutrition. In chronic malnutrition, attention should also be paid to deficiency of micronutrients such as copper, which can lead to haematologic problems.


Subject(s)
Anemia/etiology , Child Nutrition Disorders/complications , Copper/deficiency , Deficiency Diseases/complications , Leukopenia/etiology , Anorexia , Child , Child Nutrition Disorders/therapy , Chronic Disease , Deficiency Diseases/therapy , Dietary Supplements , Enteral Nutrition , Gastrectomy , Humans , Ileostomy , Male , Parenteral Nutrition , Patient Compliance , Superior Mesenteric Artery Syndrome , Vomiting , Weight Loss
13.
Nutrients ; 11(1)2019 Jan 15.
Article in English | MEDLINE | ID: mdl-30650544

ABSTRACT

In Australia, pregnant women are advised to take an iodine supplement (I-supp) (150 µg/day) to reduce risks to the foetus associated with iodine deficiency (ID). To examine the impact of this recommendation on iodine status, and to identify factors that contribute to adequacy during gestation, supplement use and Urinary Iodine Concentration (UIC) was measured in 255 pregnant women (gestation range 6 to 41 weeks) in Tasmania. The median UIC (MUIC) of 133 µg/L (Inter-quartile range 82⁻233) was indicative of ID, being below the 150⁻249 µg/L range for adequacy during pregnancy. Women taking an iodine-containing-supplement (I-supp) had a significantly higher MUIC (155 µg/L) (n = 171) compared to the combined MUIC (112.5 µg/L) (n = 84) of those who had never (120 µg/L) (n = 61) or were no longer taking an I-supp (90 µg/L) (n = 23) (p = 0.017). Among women reporting I-supp use, the MUIC of those commencing the recommended 150 µg/day prior to conception was significantly higher than those starting supplementation following pregnancy confirmation: 196 (98⁻315) µg/L (n = 45) versus 137.5 (82.5⁻233.5) µg/L (n = 124), p = 0.032. Despite recommendations for iodine supplementation pregnant Tasmanian women remain at risk of ID. Commencing an I-supp of 150 µg/day prior to conception and continuing throughout pregnancy is required to ensure adequacy. Timely advice regarding the importance of adequate iodine nutrition, including supplementation is needed to reduce the risk of irreversible in utero neurocognitive damage to the foetus.


Subject(s)
Deficiency Diseases/prevention & control , Dietary Supplements , Iodine/therapeutic use , Nutritional Status , Preconception Care , Pregnancy Complications/prevention & control , Adolescent , Adult , Australia , Deficiency Diseases/complications , Female , Fertilization , Humans , Iodine/deficiency , Iodine/urine , Middle Aged , Pregnancy , Tasmania , Young Adult
14.
Nutrients ; 11(1)2019 Jan 18.
Article in English | MEDLINE | ID: mdl-30669313

ABSTRACT

Quality protein maize (QPM) varieties are biofortified, or nutritionally improved, to have higher lysine and tryptophan levels to increase quality protein intakes particularly among young children. This study assesses adequacy of children's protein intakes in Ethiopia, where QPM is being promoted, accounting for protein quality and seasonal dietary changes, and estimates potential increases in intakes if QPM replaced conventional maize in diets. Diets of randomly sampled children aged 12⁻36 months in rural southern Ethiopia (n = 218) were assessed after harvest during relative food security and 3⁻4 months later during relative food insecurity using 24-h weighed food records. Diets were analyzed for protein adequacy, accounting for protein quality using the protein digestibility corrected amino acid score (PDCAAS) method, and potential improvements from QPM substitution were estimated. Stunting was prevalent (38%) at the first assessment. Across seasons, 95⁻96% of children consumed maize, which provided 59⁻61% of energy and 51⁻55% of total protein in 24 h. Dietary intakes decreased in the food insecure season, though children were older. Among children no longer breastfeeding, QPM was estimated to reduce inadequacy of utilizable protein intakes from 17% to 13% in the food secure season and from 34% to 19% in the food insecure season. However, breastfed children had only 4⁻6% inadequate intakes of utilizable protein, limiting QPM's potential impact. Due to small farm sizes, maize stores from home production lasted a median of three months. Young Ethiopian children are at risk of inadequate quality protein intakes, particularly after breastfeeding has ceased and during food insecurity. QPM could reduce this risk; however, reliance on access through home production may result in only short-term benefits given the limited quantities of maize produced and stored.


Subject(s)
Deficiency Diseases/prevention & control , Diet , Dietary Proteins/administration & dosage , Edible Grain , Plant Breeding , Plant Proteins/administration & dosage , Zea mays/chemistry , Amino Acids/analysis , Child, Preschool , Deficiency Diseases/complications , Dietary Proteins/analysis , Dietary Proteins/standards , Dietary Proteins/therapeutic use , Energy Intake , Ethiopia , Feeding Behavior , Female , Food Supply , Gardening , Growth Disorders/epidemiology , Growth Disorders/etiology , Growth Disorders/prevention & control , Humans , Infant , Infant Nutritional Physiological Phenomena , Male , Nutritional Status , Plant Proteins/analysis , Plant Proteins/therapeutic use , Program Evaluation , Rural Population , Seasons , Zea mays/classification
15.
Clin Nutr ; 38(2): 800-805, 2019 04.
Article in English | MEDLINE | ID: mdl-29551406

ABSTRACT

INTRODUCTION: Heart failure (HF) is a growing public health issue; its risk factors include inappropriate dietary intake of microelements such as iodine, selenium, zinc and iron, which may lead to thyroid dysfunction. OBJECTIVE: This study aimed to assess the correlation among the functional class stages of patients with HF, iodine, selenium, iron and zinc levels with the presence of thyroid dysfunction. METHODOLOGY: One hundred nine patients from the HF outpatient clinic of the Clinics Hospital of Ribeirão Preto whose blood and urine were collected for micronutrient analysis and laboratory tests were selected. The subjects' weight and height were also measured to calculate their BMI. First, a descriptive analysis of the data was made into tables, and then statistical analyses were done at a 5% significance level (p < 0.05). RESULTS: Most patients whose data was analysed were elderly and overweight. Excess ioduria, serum selenium and zinc, erythrocyte zinc and deficiency in serum iron and erythrocyte selenium were observed. The prevalence of thyroid dysfunction was 8.3%. Multivariate logistic regression verified that thyroid dysfunction increases the chance of classification in functional class III or IV (p = 0.015; OR = 8.72) by 8.7 times; each year of age increases the chance by 4.6% of classification in functional class III or IV (p = 0.008; odds ratio [OR] = 1.05), and each unit of BMI increases the chance of classification in functional class III or IV by 9.2% (p = 0.028; OR = 1.09). CONCLUSION: Patients with HF were deficient in serum iron and erythrocyte selenium. No connection was found between hypothyroidism and mineral deficiency, which seems to be related more to the severity of the disease than to the micronutrient nutritional profile.


Subject(s)
Deficiency Diseases , Heart Failure , Hypothyroidism , Micronutrients/deficiency , Adult , Aged , Cross-Sectional Studies , Deficiency Diseases/complications , Deficiency Diseases/epidemiology , Female , Heart Failure/complications , Heart Failure/epidemiology , Humans , Hypothyroidism/complications , Hypothyroidism/epidemiology , Iodine/deficiency , Male , Middle Aged , Nutritional Status/physiology , Selenium/deficiency , Zinc/deficiency
16.
Nutrients ; 10(9)2018 Sep 09.
Article in English | MEDLINE | ID: mdl-30205599

ABSTRACT

Inadequate iodine status affects the synthesis of the thyroid hormones and may impair brain development in fetal life. The aim of this study was to explore the association between maternal iodine status in pregnancy measured by urinary iodine concentration (UIC) and child neurodevelopment at age 6, 12 and 18 months in a population-based cohort. In total, 1036 families from nine locations in Norway were enrolled in the little in Norway cohort. The present study includes n = 851 mother-child pairs with singleton pregnancies, no use of thyroid medication in pregnancy, no severe genetic disorder, data on exposure (UIC) in pregnancy and developmental outcomes (Bayley Scales of Infant and Toddler Development, third edition). Data collection also included general information from questionnaires. We examined associations between UIC (and use of iodine-containing supplements) and repeated measures of developmental outcomes using multivariable mixed models. The median UIC in pregnancy was 78 µg/L (IQR 46⁻130), classified as insufficient iodine intake according to the WHO. Eighteen percent reported use of iodine-containing multisupplements. A UIC below ~100 was associated with reduced receptive (p = 0.025) and expressive language skills (p = 0.002), but not with reduced cognitive or fine- and gross motor skills. Maternal use of iodine-containing supplements was associated with lower gross motor skills (b = -0.18, 95% CI = -0.33, -0.03, p = 0.02), but not with the other outcome measures. In conclusion, an insufficient iodine intake in pregnancy, reflected in a UIC below ~100 µg/L, was associated with lower infant language skills up to 18 months. The use of iodine-containing supplements was not associated with beneficial effects.


Subject(s)
Child Language , Deficiency Diseases/urine , Infant Behavior , Iodine/urine , Maternal Nutritional Physiological Phenomena , Nutritional Status , Prenatal Exposure Delayed Effects , Age Factors , Biomarkers/urine , Cognition , Deficiency Diseases/complications , Deficiency Diseases/diagnosis , Deficiency Diseases/physiopathology , Dietary Supplements , Female , Humans , Infant , Iodine/deficiency , Male , Motor Skills , Pregnancy , Prospective Studies , Risk Factors
17.
Br J Nutr ; 120(6): 693-702, 2018 09.
Article in English | MEDLINE | ID: mdl-30068404

ABSTRACT

Findings from clinical trials on the effect of Mg supplementation on depression and anxiety are not generalisable to the community owing to high-dose intervention in short-term periods. Limited observational data are available linking dietary intake of Mg and psychiatric disorders. We aimed to investigate the association between dietary intake of Mg and psychiatric disorders in a large cross-sectional study on Iranian adults. A total of 3172 Iranian adults (with an age range of 18-55 years) were included in this study. Data on dietary intakes were collected using a validated dish-based 106-item semi-quantitative FFQ. To assess depression and anxiety, an Iranian validated version of the Hospital Anxiety and Depression Scale was used. Furthermore, psychological distress was examined using the General Health Questionnaire. The mean age of men and women was 38·4 (sd 8·2) and 35·1 (sd 7·4) years, respectively. In unadjusted analyses, we found that higher dietary Mg intake was associated with lower odds of anxiety among women (OR 0·61; 95 % CI 0·41, 0·90), such that after taking potential confounders into account women in the highest quintile of Mg intake had a 39 % lower odds of anxiety compared with those in the lowest quintile (OR 0·61; 95 % CI 0·40, 0·93). Moreover, deficient Mg intake was positively associated with anxiety among all women (OR 1·80; 95 % CI 1·19, 2·72) and also normal-weight women (OR 1·73; 95 % CI 1·01, 2·95). In addition, a significant inverse association was found between dietary Mg intake and depression among normal-weight men (OR 0·45; 95 % CI 0·20, 0·99) and overweight women (OR 0·45; 95 % CI 0·24, 0·85). In conclusion, dietary intake of Mg was inversely associated with depression and anxiety. However, such findings were not seen for psychological distress.


Subject(s)
Anxiety Disorders/prevention & control , Anxiety/prevention & control , Depression/prevention & control , Depressive Disorder/prevention & control , Diet , Magnesium/therapeutic use , Trace Elements/therapeutic use , Adolescent , Adult , Anxiety/etiology , Cross-Sectional Studies , Deficiency Diseases/complications , Feeding Behavior , Female , Humans , Iran , Male , Middle Aged , Obesity/complications , Obesity/psychology , Odds Ratio , Sex Factors , Stress, Psychological , Surveys and Questionnaires , Young Adult
18.
Nutrients ; 10(7)2018 Jul 17.
Article in English | MEDLINE | ID: mdl-30018262

ABSTRACT

Adverse effects of low vitamin D status and calcium intakes in pregnancy may be mediated through functional effects on the calcium metabolic system. Little explored in pregnancy, we aimed to examine the relative importance of serum 25-hydroxyvitamin D (25(OH)D) and calcium intake on parathyroid hormone (PTH) concentrations in healthy white-skinned pregnant women. This cross-sectional analysis included 142 participants (14 ± 2 weeks' gestation) at baseline of a vitamin D intervention trial at 51.9 °N. Serum 25(OH)D, PTH, and albumin-corrected calcium were quantified biochemically. Total vitamin D and calcium intakes (diet and supplements) were estimated using a validated food frequency questionnaire. The mean ± SD vitamin D intake was 10.7 ± 5.2 µg/day. With a mean ± SD serum 25(OH)D of 54.9 ± 22.6 nmol/L, 44% of women were <50 nmol/L and 13% <30 nmol/L. Calcium intakes (mean ± SD) were 1182 ± 488 mg/day and 23% of participants consumed <800 mg/day. The mean ± SD serum albumin-adjusted calcium was 2.2 ± 0.1 mmol/L and geometric mean (95% CI) PTH was 9.2 (8.4, 10.2) pg/mL. PTH was inversely correlated with serum 25(OH)D (r = -0.311, p < 0.001), but not with calcium intake or serum calcium (r = -0.087 and 0.057, respectively, both p > 0.05). Analysis of variance showed that while serum 25(OH)D (dichotomised at 50 nmol/L) had a significant effect on PTH (p = 0.025), calcium intake (<800, 800⁻1000, ≥1000 mg/day) had no effect (p = 0.822). There was no 25(OH)D-calcium intake interaction effect on PTH (p = 0.941). In this group of white-skinned women with largely sufficient calcium intakes, serum 25(OH)D was important for maintaining normal PTH concentration.


Subject(s)
Calcium, Dietary/administration & dosage , Diet, Healthy , Dietary Supplements , Maternal Nutritional Physiological Phenomena , Nutritional Status , Parathyroid Hormone/blood , Vitamin D/administration & dosage , 25-Hydroxyvitamin D 2/blood , Adult , Calcifediol/blood , Calcium/blood , Calcium/deficiency , Calcium, Dietary/therapeutic use , Cross-Sectional Studies , Deficiency Diseases/complications , Deficiency Diseases/epidemiology , Deficiency Diseases/prevention & control , Female , Humans , Ireland/epidemiology , Parathyroid Hormone/metabolism , Pregnancy , Pregnancy Complications/epidemiology , Pregnancy Complications/prevention & control , Prospective Studies , Risk , Skin Pigmentation , Vitamin D/therapeutic use , Vitamin D Deficiency/complications , Vitamin D Deficiency/epidemiology , Vitamin D Deficiency/prevention & control
19.
Article in German | MEDLINE | ID: mdl-29902819

ABSTRACT

This case report presents investigations of muscle problems in three male water buffaloes (1-2 years) kept extensively (loose housing, pasture). The bulls were presented because of listlessness and increased lying periods. They displayed difficulties to stand up, a stilted gait, and tremor in the legs. The determination of the selenium concentration by the measurement of glutathione peroxidase activity in whole blood samples (EDTA) demonstrated selenium deficiency in all three buffaloes. This confirmed the tentative diagnosis of nutritive myodystrophy due to selenium deficiency. Following a single injection of 1500 mg all-rac-alpha-tocopherol acetate and 11 mg sodium selenite, the bulls recovered clinically. The whole blood samples taken subsequently from seven adult water buffaloes on the farm showed selenium deficiency in all animals. Consequently, slow-release multi-trace element boluses were administered once orally - as far as possible - to all adult animals of the herd. After 1 year, a good to very good selenium supply was observed in all these buffaloes, except for one cow, in which bolus application had failed.


Subject(s)
Buffaloes , Deficiency Diseases/veterinary , Organic Agriculture , Selenium/deficiency , Animal Husbandry/methods , Animals , Deficiency Diseases/complications , Deficiency Diseases/drug therapy , Farms , Male , Muscular Dystrophies/etiology , Sodium Selenite/administration & dosage , alpha-Tocopherol/administration & dosage
20.
Adv Nutr ; 9(3): 219-237, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29767700

ABSTRACT

Hypothyroidism due to iodine deficiency can impair physical development, most visibly in the marked stunting of myxedematous cretinism caused by severe in utero iodine deficiency. Whether iodine repletion improves growth in noncretinous children is uncertain. Therefore, the aim of our systematic review was to assess the effects of iodine fortification or supplementation on prenatal and postnatal growth outcomes in noncretinous children. Following Cochrane methods and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) reporting guidelines, we searched 10 databases including 2 Chinese databases (latest search February 2017). We included randomized and nonrandomized controlled trials (RCTs; non-RCTs), controlled before-after (CBA) studies, and interrupted time-series studies in pregnant women and children (≤18 y), which compared the effects of iodine (any form, dose, regimen) to placebo, noniodized salt, or no intervention on prenatal and postnatal growth outcomes. We calculated mean differences with 95% CIs, performed random-effects meta-analyses, and assessed the quality of evidence with the use of GRADE (Grading of Recommendations Assessment, Development and Evaluation). We included 18 studies (13 RCTs, 4 non-RCTs, 1 CBA) (n = 5729). Iodine supplementation of severely iodine-deficient pregnant women increased mean birthweight [mean difference (MD): 200 g; 95% CI: 183, 217 g; n = 635; 2 non-RCTs] compared to controls, but the quality of this evidence was assessed as very low. Iodine repletion across the other groups showed no effects on primary growth outcomes (quality of evidence mostly low and very low). Meta-analyses showed a positive effect in moderate-to-mildly iodine-deficient schoolchildren on insulin-like growth factor-1 (MD: 38.48 ng/mL; 95% CI: 6.19, 70.76 ng/mL; n = 498; 2 RCTs, low-quality evidence) and insulin-like growth factor binding protein-3 (MD: 0.46 µg/mL; 95% CI: 0.25, 0.66 µg/mL; n = 498; 2 RCTs, low-quality evidence). In conclusion, we identified few well-designed trials examining the effects of iodine repletion on growth. We are uncertain whether prenatal iodine repletion increases infant growth. Postnatal iodine repletion may improve growth factors but has no clear effects on somatic growth. Our systematic review was registered with PROSPERO as CRD42014012940.


Subject(s)
Deficiency Diseases/complications , Dietary Supplements , Fetal Growth Retardation/prevention & control , Food, Fortified , Growth Disorders/prevention & control , Iodine/therapeutic use , Sodium Chloride, Dietary , Birth Weight/drug effects , Female , Fetal Growth Retardation/etiology , Growth Disorders/etiology , Humans , Iodine/deficiency , Iodine/pharmacology , Maternal Nutritional Physiological Phenomena , Pregnancy , Pregnancy Complications/etiology , Pregnancy Complications/prevention & control , Sodium Chloride, Dietary/pharmacology , Sodium Chloride, Dietary/therapeutic use , Somatomedins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL